Skip to main content

The Clinical Use of Biologics in the Knee Lesions: Does the Patient Benefit?

Abstract

Purpose of Review

Overview the outcomes of the latest use of platelet-rich plasma (PRP) for the treatment of knee lesions in the clinics and discuss the challenges and limitations.

Recent Findings

Recent clinical studies mainly indicate there may be benefit of PRP usage for the treatment of knee lesions. As an autologous source of bioactive components, PRP has been shown to be typically safe, free of major adverse outcomes. The use of PRP has been continuously increasing, and some well-designed, double-blinded, placebo-controlled clinical trials have been published.

Summary

Clinical outcomes relating to PRP usage are multifactorial and depend on the severity of the lesion and patient characteristics. Although PRP is safe to use and it can be easily applied in the clinics, case-specific considerations are needed to determine whether PRP could be beneficial or not. If the use of PRP is favored, then, the configuration/optimization of the preparation and administration/delivery strategy with or without a concomitant treatment may further enhance the clinical outcomes and patients’ experience.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.

    Cengiz IF, Pereira H, Espregueira-Mendes J, Oliveira JM, Reis RL. Treatments of meniscus lesions of the knee: current concepts and future perspectives. Regen Eng Transl Med. 2017;3(1):32–50.

    Article  Google Scholar 

  2. 2.

    Gomoll A, Filardo G, De Girolamo L, Esprequeira-Mendes J, Marcacci M, Rodkey W, et al. Surgical treatment for early osteoarthritis. Part I: cartilage repair procedures. Knee Surg Sports Traumatol Arthrosc. 2012;20(3):450–66.

    CAS  Article  Google Scholar 

  3. 3.

    Heijink A, Gomoll AH, Madry H, Drobnič M, Filardo G, Espregueira-Mendes J, et al. Biomechanical considerations in the pathogenesis of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2012;20(3):423–35.

    Article  Google Scholar 

  4. 4.

    Pereira H, Cengiz IF, Vilela C, Ripoll PL, Espregueira-Mendes J, Oliveira JM et al. Emerging concepts in treating cartilage, osteochondral defects, and osteoarthritis of the knee and ankle. Osteochondral Tissue Engineering. Springer; 2018. p. 25–62.

  5. 5.

    Vannini F, Spalding T, Andriolo L, Berruto M, Denti M, Espregueira-Mendes J, et al. Sport and early osteoarthritis: the role of sport in aetiology, progression and treatment of knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2016;24(6):1786–96.

    CAS  Article  Google Scholar 

  6. 6.

    Cengiz IF, Pereira H, de Girolamo L, Cucchiarini M, Espregueira-Mendes J, Reis RL, et al. Orthopaedic regenerative tissue engineering en route to the holy grail: disequilibrium between the demand and the supply in the operating room. J Exp Orthop. 2018;5(1):14.

    Article  Google Scholar 

  7. 7.

    Delanois RE, Etcheson JI, Sodhi N, Henn RF III, Gwam CU, George NE, et al. Biologic therapies for the treatment of knee osteoarthritis. J Arthroplast. 2018.

  8. 8.

    Makris EA, Gomoll AH, Malizos KN, Hu JC, Athanasiou KA. Repair and tissue engineering techniques for articular cartilage. Nat Rev Rheumatol. 2015;11(1):21–34.

    CAS  Article  Google Scholar 

  9. 9.

    Huang BJ, Hu JC, Athanasiou KA. Cell-based tissue engineering strategies used in the clinical repair of articular cartilage. Biomaterials. 2016;98:1–22.

    CAS  Article  Google Scholar 

  10. 10.

    Pereira H, Frias AM, Oliveira JM, Espregueira-Mendes J, Reis RL. Tissue engineering and regenerative medicine strategies in meniscus lesions. Arthroscopy. 2011;27(12):1706–19.

    Article  Google Scholar 

  11. 11.

    Smith BD, Grande DA. The current state of scaffolds for musculoskeletal regenerative applications. Nat Rev Rheumatol. 2015;11(4):213–22.

    CAS  Article  Google Scholar 

  12. 12.

    Cengiz IF, Oliveira JM, Ochi M, Nakamae A, Adachi N, Reis RL. “Biologic” treatment for meniscal repair. Injuries and health problems in football. Springer; 2017. p. 679–686

  13. 13.

    Wasserman A, Matthewson G, MacDonald P. Platelet-rich plasma and the knee—applications in orthopedic surgery. Curr Rev Musculoskelet Med. 2018;11(4):607–15.

    Article  Google Scholar 

  14. 14.

    Cucchiarini M, Madry H. Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair. Nat Rev Rheumatol. 2018;(1).

  15. 15.

    Venkatesan JK, Rey-Rico A, Cucchiarini M. Current trends in viral gene therapy for human orthopaedic regenerative medicine. Tissue Eng Regen Med. 2019:1–11.

  16. 16.

    Cengiz IF, Oliveira JM, Reis RL. PRP therapy. Osteochondral Tissue Engineering. Springer; 2018. p. 241–53.

  17. 17.

    Le AD, Enweze L, DeBaun MR, Dragoo JL. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11(4):624–34.

    Article  Google Scholar 

  18. 18.

    Wasterlain AS, Braun HJ, Dragoo JL. The systemic effects of platelet-rich plasma. Platelet rich plasma in musculoskeletal practice: Springer; 2016. p. 199–222.

  19. 19.

    Mitchell AC, Briquez PS, Hubbell JA, Cochran JR. Engineering growth factors for regenerative medicine applications. Acta Biomater. 2016;30:1–12.

    CAS  Article  Google Scholar 

  20. 20.

    Subbiah R, Guldberg RE. Materials science and design principles of growth factor delivery systems in tissue engineering and regenerative medicine. Adv Healthc Mater. 2019;8(1):1801000.

    Article  Google Scholar 

  21. 21.

    Everts PA, Knape JT, Weibrich G, Schonberger J, Hoffmann J, Overdevest EP, et al. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol. 2006;38(2):174–87.

    PubMed  PubMed Central  Google Scholar 

  22. 22.

    Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008;(13):3532–48.

  23. 23.

    Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16(6):1043–54.

    Article  Google Scholar 

  24. 24.

    Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259–72.

    Article  Google Scholar 

  25. 25.

    Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225–8.

    CAS  Article  Google Scholar 

  26. 26.

    Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:489–96.

    Article  Google Scholar 

  27. 27.

    Metcalf KB, Mandelbaum BR, McIlwraith CW. Application of platelet-rich plasma to disorders of the knee joint. Cartilage. 2013;4(4):295–312.

    Article  Google Scholar 

  28. 28.

    Cerza F, Carnì S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40(12):2822–7.

    Article  Google Scholar 

  29. 29.

    Filardo G, Kon E, Di Martino A, Di Matteo B, Merli ML, Cenacchi A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012;13(1):229.

    CAS  Article  Google Scholar 

  30. 30.

    Hart R, Safi A, Komzák M, Jajtner P, Puskeiler M, Hartová P. Platelet-rich plasma in patients with tibiofemoral cartilage degeneration. Arch Orthop Trauma Surg. 2013;133(9):1295–301.

    Article  Google Scholar 

  31. 31.

    Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41(2):356–64.

    Article  Google Scholar 

  32. 32.

    Sanchez M, Fiz N, Azofra J, Usabiaga J, Recalde EA, Gutierrez AG, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28(8):1070–8.

    Article  Google Scholar 

  33. 33.

    Spakova T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91(5):411–7.

    Article  Google Scholar 

  34. 34.

    Filardo G, Kon E, Ruiz MTP, Vaccaro F, Guitaldi R, Di Martino A, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single-versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20(10):2082–91.

    Article  Google Scholar 

  35. 35.

    Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27(11):1490–501.

    Article  Google Scholar 

  36. 36.

    Say F, Gürler D, Yener K, Bülbül M, Malkoc M. Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chir Orthop Traumatol Cechoslov. 2013;80(4):278–83.

    CAS  Google Scholar 

  37. 37.

    • Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole BJ. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med. 2016;44(3):792–800. This work reports the effect of leukocyte concentration in PRP for the treatment of knee osteoarthritis.

    Article  Google Scholar 

  38. 38.

    Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721–30.

    CAS  Article  Google Scholar 

  39. 39.

    Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee. Curr Rev Musculoskelet Med. 2018;11(4):583–92.

    Article  Google Scholar 

  40. 40.

    Fice MP, Miller JC, Christian R, Hannon CP, Smyth N, Murawski CD, et al. The role of platelet-rich plasma in cartilage pathology: an updated systematic review of the basic science evidence. Arthroscopy. 2019;35:961–976.e3.

    Article  Google Scholar 

  41. 41.

    •• Filardo G, Kon E, Roffi A, Di Matteo B, Merli M, Marcacci M. Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee Surg Sports Traumatol Arthrosc. 2013:1–16. This is a valuable systematic review on the in vitro , in vivo , and the clinical studies about PRP for joint degeneration.

  42. 42.

    Kennedy MI, Whitney K, Evans T, LaPrade RF. Platelet-rich plasma and cartilage repair. Curr Rev Musculoskelet Med. 2018;11(4):573–82.

    Article  Google Scholar 

  43. 43.

    Kia C, Baldino J, Bell R, Ramji A, Uyeki C, Mazzocca A. Platelet-rich plasma: review of current literature on its use for tendon and ligament pathology. Curr Rev Musculoskelet Med. 2018;11(4):566–72.

    Article  Google Scholar 

  44. 44.

    Laver L, Marom N, Dnyanesh L, Mei-Dan O, Espregueira-Mendes J, Gobbi A. PRP for degenerative cartilage disease: a systematic review of clinical studies. Cartilage. 2017;8(4):341–64.

    CAS  Article  Google Scholar 

  45. 45.

    Sanchez M, Delgado D, Garate A, Sánchez P, Padilla S, Azofra J. Platelet-rich plasma combined with allograft to treat osteochondritis dissecans of the knee: a case report. J Med Case Rep. 2019;13(1):105.

    Article  Google Scholar 

  46. 46.

    Koch M, Mayr F, Achenbach L, Krutsch W, Lang S, Hilber F, et al. Partial anterior cruciate ligament ruptures: advantages by intraligament autologous conditioned plasma injection and healing response technique—midterm outcome evaluation. Biomed Res Int. 2018;2018:1–9.

    Article  Google Scholar 

  47. 47.

    Koch M, Matteo BD, Eichhorn J, Zellner J, Mayr F, Krutsch W, et al. Intra-ligamentary autologous conditioned plasma and healing response to treat partial ACL ruptures. Arch Orthop Trauma Surg. 2018;138(5):675–83. https://doi.org/10.1007/s00402-018-2885-1.

    Article  PubMed  Google Scholar 

  48. 48.

    •• Scott A, LaPrade RF, Harmon KG, Filardo G, Kon E, Della Villa S et al. Platelet-rich plasma for patellar tendinopathy: a randomized controlled trial of leukocyte-rich PRP or leukocyte-poor PRP versus saline. Am J Sports Med 2019:0363546519837954. This work compares leukocyte-rich and -poor PRP for patellar tendinopathy treatment.

  49. 49.

    Dai W-L, Zhang H, Lin Z-M, Shi Z-J, Wang J. Efficacy of platelet-rich plasma in arthroscopic repair for discoid lateral meniscus tears. BMC Musculoskelet Disord. 2019;20(1):113.

    Article  Google Scholar 

  50. 50.

    Zhang H, Chen S, Qiu M, Zhou A, Yan W, Zhang J. Lateral meniscus allograft transplantation with platelet-rich plasma injections: a minimum two-year follow-up study. Knee. 2018;25(4):568–76.

    Article  Google Scholar 

  51. 51.

    Kemmochi M, Sasaki S, Takahashi M, Nishimura T, Aizawa C, Kikuchi J. The use of platelet-rich fibrin with platelet-rich plasma support meniscal repair surgery. J Orthop. 2018;15(2):711–20.

    Article  Google Scholar 

  52. 52.

    Cengiz IF, Pereira H, Silva-Correia J, Ripoll PL, Espregueira-Mendes J, Kaz R et al. Meniscal lesions: from basic science to clinical management in footballers. Injuries and health problems in football. Springer; 2017. p. 145–163.

  53. 53.

    Pereira H, Cengiz IF, Silva-Correia J, Cucciarini M, Gelber PE, Espregueira-Mendes J et al. Histology-ultrastructure-biology. Surgery of the Meniscus. Springer; 2016. p. 23–33.

  54. 54.

    Pereira H, Cengiz IF, Silva-Correia J, Ripoll PL, Varatojo R, Oliveira JM et al. Meniscal repair: indications, techniques, and outcome. Arthroscopy. Springer; 2016. p. 125–42.

  55. 55.

    • Kaminski R, Maksymowicz-Wleklik M, Kulinski K, Kozar-Kaminska K, Dabrowska-Thing A, Pomianowski S. Short-term outcomes of percutaneous trephination with a platelet rich plasma intrameniscal injection for the repair of degenerative meniscal lesions. A prospective, randomized, double-blind, parallel-group, placebo-controlled study. Int J Mol Sci. 2019;20(4):856. This work investigates how PRP can augment the repair of degenerative meniscal lesions on a limited number of patients.

    CAS  Article  Google Scholar 

  56. 56.

    • Kaminski R, Kulinski K, Kozar-Kaminska K, Wielgus M, Langner M, Wasko MK, et al. A prospective, randomized, double-blind, parallel-group, placebo-controlled study evaluating meniscal healing, clinical outcomes, and safety in patients undergoing meniscal repair of unstable, complete vertical meniscal tears (bucket handle) augmented with platelet-rich plasma. Biomed Res Int. 2018;2018. This study analyzing the effects of PRP on the repair of bucket handle meniscal lesions in a limited number of patients.

  57. 57.

    Bastos R, Mathias M, Andrade R, Bastos R, Balduino A, Schott V, et al. Intra-articular injections of expanded mesenchymal stem cells with and without addition of platelet-rich plasma are safe and effective for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2018;26(11):3342–50.

    Article  Google Scholar 

  58. 58.

    Huang G, Hua S, Yang T, Ma J, Yu W, Chen X. Platelet-rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors. Exp Ther Med. 2018;15(3):3096–102.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. 59.

    Buendia-Lopez D, Medina-Quirós M, Marín MÁF-V. Clinical and radiographic comparison of a single LP-PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up: a randomized controlled trial. J Orthop Traumatol. 2018;19(1):3.

    Article  Google Scholar 

  60. 60.

    •• Di Martino A, Di Matteo B, Papio T, Tentoni F, Selleri F, Cenacchi A, et al. Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: results at 5 years of a double-blind, randomized controlled trial. Am J Sports Med. 2019;47(2):347–54. This is a well-designed study that compares the PRP with hyaluronic acid for the treatment of knee osteoarthritis: Results at 5 Years of a Double-Blind, Randomized Controlled Trial.

    Article  Google Scholar 

  61. 61.

    Ahmad HS, Farrag SE, Okasha AE, Kadry AO, Ata TB, Monir AA, et al. Clinical outcomes are associated with changes in ultrasonographic structural appearance after platelet-rich plasma treatment for knee osteoarthritis. Int J Rheum Dis. 2018;21(5):960–6.

    CAS  Article  Google Scholar 

  62. 62.

    Louis ML, Magalon J, Jouve E, Bornet CE, Mattei JC, Chagnaud C, et al. Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: a randomized double blind noninferiority trial compared with viscosupplementation. Arthroscopy. 2018;34(5):1530–40 e2.

    Article  Google Scholar 

  63. 63.

    Yu W, Xu P, Huang G, Liu L. Clinical therapy of hyaluronic acid combined with platelet-rich plasma for the treatment of knee osteoarthritis. Exp Ther Med. 2018;16(3):2119–25.

    PubMed  PubMed Central  Google Scholar 

  64. 64.

    Camurcu Y, Sofu H, Ucpunar H, Kockara N, Cobden A, Duman S. Single-dose intra-articular corticosteroid injection prior to platelet-rich plasma injection resulted in better clinical outcomes in patients with knee osteoarthritis: a pilot study. J Back Musculoskelet Rehabil. 2018(Preprint):1–8.

  65. 65.

    Guillibert C, Charpin C, Raffray M, Benmenni A, Dehaut F-X, El Ghobeira G, et al. Single injection of high volume of autologous pure PRP provides a significant improvement in knee osteoarthritis: a prospective routine care study. Int J Mol Sci. 2019;20(6):1327.

    Article  Google Scholar 

  66. 66.

    Huang Y, Liu X, Xu X, Liu J. Intra-articular injections of platelet-rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis. Orthopade. 2019;48(3):239–47.

    Article  Google Scholar 

  67. 67.

    Li TY, Wu YT, Chen LC, Cheng SN, Pan RY, Chen YC. An exploratory comparison of single intra-articular injection of platelet-rich plasma vs hyaluronic acid in treatment of haemophilic arthropathy of the knee. Haemophilia. 2019;25:484–92.

    CAS  Article  Google Scholar 

  68. 68.

    Lin K-Y, Yang C-C, Hsu C-J, Yeh M-L, Renn J-H. Intra-articular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: a randomized, double-blind, triple-parallel, placebo-controlled clinical trial. Arthroscopy. 2019;35(1):106–17.

    Article  Google Scholar 

  69. 69.

    Su K, Bai Y, Wang J, Zhang H, Liu H, Ma S. Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis. Clin Rheumatol. 2018;37(5):1341–50.

    Article  Google Scholar 

  70. 70.

    Chen CP, Chen J-L, Hsu C-C, Pei Y-C, Chang W-H, Lu H-C. Injecting autologous platelet rich plasma solely into the knee joint is not adequate in treating geriatric patients with moderate to severe knee osteoarthritis. Exp Gerontol. 2019;119:1–6.

    Article  Google Scholar 

  71. 71.

    Fréchette J-P, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res. 2005;84(5):434–9.

    Article  Google Scholar 

  72. 72.

    Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011;39(2):266–71.

    Article  Google Scholar 

  73. 73.

    Magalon J, Bausset O, Serratrice N, Giraudo L, Aboudou H, Veran J, et al. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy. 2014;30(5):629–38.

    Article  Google Scholar 

  74. 74.

    • Bishop FL, Coghlan B, Geraghty AW, Everitt H, Little P, Holmes MM, et al. What techniques might be used to harness placebo effects in non-malignant pain? A literature review and survey to develop a taxonomy. BMJ Open. 2017;7(6):e015516. Placebo effect can have clinical value. This study reviews the placebo effect and contributes to the development of a taxonomy.

    Article  Google Scholar 

  75. 75.

    Domzalski ME, Szkutnik P. Emerging orthobiologic approach to fractures. Bio-orthopaedics. Springer; 2017. p. 473–478.

  76. 76.

    Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226–33.

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the Portuguese Foundation for Science and Technology (FCT) project M-ERA-NET/0001/2014 project. This work is also a result of the project FROnTHERA

(NORTE-01-0145-FEDER-000023), supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). IFC thanks the FCT for the grant SFRH/BD/99555/2014. JMO also thanks the FCT for the funds provided under the program Investigador FCT 2015 (IF/01285/2015).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Ibrahim Fatih Cengiz.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Human and Animal Rights and Informed Consent

This paper does not contain any studies with human or animal subjects performed the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Outcomes Research in Orthopedics

Electronic supplementary material

ESM 1

(DOCX 15 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cengiz, I.F., Pereira, H., Espregueira-Mendes, J. et al. The Clinical Use of Biologics in the Knee Lesions: Does the Patient Benefit?. Curr Rev Musculoskelet Med 12, 406–414 (2019). https://doi.org/10.1007/s12178-019-09573-3

Download citation

Keywords

  • Platelet-rich plasma
  • Knee
  • Osteoarthritis
  • Meniscus
  • Ligament
  • Biologics